logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
15/05/2025
HC Wainwright & Co.: Maintains a Buy rating on ArriVent BioPharma (AVBP.US), adjusted from a Buy rating, with a target price adjusted from $39.00 to $40.00.
Latest
1 m ago
The economic advisory team of Japanese Prime Minister Shigeru Ishiba has proposed investing $400 billion to improve the productivity of small and medium-sized enterprises, a key measure for the government to achieve wage growth far above the inflation rate. The team submitted an outline of a five-year plan at a meeting on Wednesday, outlining measures to support small and medium-sized enterprises in increasing wages. The team is responsible for formulating key economic policies for the government. Specific measures include investing 60 trillion yen (about $407.86 billion) over the next five years in both the public and private sectors to help small and medium-sized enterprises digitize or automate their operations, while also increasing support for mergers and acquisitions.
2 m ago
Hedge fund tycoon Steve Cohen believes there is currently a 45% possibility of a recession in the United States.
2 m ago
Nvidia's "darling son" CoreWeave experiences a post-market earthquake, surging over 11% at one point and now dropping over 7%; the company's Q1 revenue surpasses expectations with a year-on-year increase of 420%, but the net loss has expanded to $315 million.
3 m ago
South Korean Lotte seeks to sell its logistics center to raise funds.
4 m ago
Shenzhen's industrial chain advantage promotes the acceleration of the development of artificial intelligence technology.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.